Han Ying's most recent trade in Gyre Therapeutics Inc was a trade of 341,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 14, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Gyre Therapeutics Inc | Han Ying | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 341,000 | 341,000 | - | - | Stock Option (Right to Buy) |